Trial intelligence / Profile preview

Amnion-derived Collagen vs PRP for Facial Wrinkles

NCT06054646Phase 2Completed

Sponsor
Egyptian Atomic Energy Authority
Start
May 2019
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 2, open-label trial in rhytides and Hyperpigmentation (2 arms), sponsored by Egyptian Atomic Energy Authority. Primary endpoints: Wrinkle Severity Rating Scale at 2 weeks, Global Aesthetic Improvement Scale at 2 weeks and 2 more. Started May 2019; status: completed.

02

Conditions

rhytidesHyperpigmentation

Beyond the preview

Go deeper on NCT06054646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06054646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call